We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Canadian Collaboration to Develop Bioterror Diagnostics

By HospiMedica staff writers
Posted on 25 Jun 2007
Nanogen (San Diego, CA, USA), a developer of advanced diagnostic products, will cooperate with Canadian authorities to develop veterinary and bioterror diagnostics. More...


Project funding was awarded by several Canadian agencies, including the Canadian Food Inspection Agency (CFIA; Ottawa). The purpose of the funding and collaborative agreement is to develop diagnostic tools for the detection of natural or potential bioterror threats to livestock, such as foot and mouth disease and avian flu, employing Nanogen's NanoChip platform. Financial terms were not disclosed.

The NanoChip 400 is an automated multiplexing platform, which uses advanced microarray technology for performing pathogen sequence detection and genotyping applications. Multiple samples with multiple targets can be applied to an open and flexible electronic microarray--the NanoChip cartridge--that may be reused until all tests sites have been utilized. As the NanoChip arrays are built by users rather than containing pre-determined content, the system provides a simple, fast, and cost-effective means for performing molecular testing.

"Although the majority of our NanoChip instruments are used in basic research and human clinical diagnostics applications, we have always known that the platform's flexibility confers benefit in other markets, such as veterinary diagnostics and the monitoring of bioterror threats,” said David Ludvigson, Nanogen president and CEO.

Foot and mouth disease, a viral infection that devastated the beef industry in the United Kingdom in 2001, is a major bioterror concern since it is easily transmissible from animal to animal.


Related Links:
Nanogen
Canadian Food Inspection Agency

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.